CVRX实时信号 | 通过Getagraph.com最大化利润

出售 106863 min ago

@ $22.95

发出时间: 14 Feb 2024 @ 22:40

回报率: -35.98%

上一信号: Feb 8 - 04:53

上一信号: 购买

回报率: -6.35 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases...

Stats
今日成交量	85 438.00
平均成交量	131 598
市值	317.24M
EPS	$0 ( 2024-04-25 )
下一个收益日期	( $-0.530 ) 2024-04-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.38
ATR14	$0.0310 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Palmer Craig E.	Buy	151	Common Stock
2024-03-25	Palmer Craig E.	Buy	404	Common Stock
2024-03-25	Palmer Craig E.	Buy	379	Common Stock
2024-03-25	Palmer Craig E.	Sell	151	Stock Option (right to buy)
2024-02-29	Johnson & Johnson	Buy	79	Common Stock

INSIDER POWER
-42.22
Last 98 transactions
Buy: 1 792 667 \| Sell: 4 181 141

音量相关性

長: 0.06 (neutral)

短: 0.98 (very strong)

Signal:(59.981) Expect same movement, but be aware

CVRx, Inc. 相关性

10 最正相关
GTHX	0.902
IMPL	0.882
MMAC	0.877
STAF	0.871
REVB	0.865
EAR	0.865
DTSS	0.863
JFU	0.86
SNGX	0.858
UPC	0.857

10 最负相关
ATCX	-0.921
CSII	-0.917
CNST	-0.916
ICON	-0.909
CNCE	-0.89
SCR	-0.887
SRRA	-0.876
TA	-0.875
MLTX	-0.872
RAMMU	-0.871

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

CVRx, Inc. 相关性 - 货币/商品

0.02
( neutral )

-0.44
( neutral )

0.00
( neutral )

0.01
( neutral )

-0.27
( neutral )

0.29
( neutral )

CVRx, Inc. 财务报表

Annual	2023
营收:	$39.30M
毛利润:	$33.04M (84.08 %)
EPS:	$-1.990

FY	2023
营收:	$39.30M
毛利润:	$33.04M (84.08 %)
EPS:	$-1.990

FY	2022
营收:	$22.47M
毛利润:	$17.47M (77.75 %)
EPS:	$-2.02

FY	2021
营收:	$13.04M
毛利润:	$9.40M (72.08 %)
EPS:	$-2.14

Financial Reports:

No articles found.

CVRx, Inc.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

实时更新： CVRx, Inc. [CVRX]

Upcoming Earnings Alert